Published on 19 Apr 2024 on Motley Fool via Yahoo Finance
The stock market certainly had its outperformers as the latest trading week came to a close, but it didn't seem Hims & Hers Health (NYSE: HIMS) would be one of them. As of the pre-market hours on Friday, the specialty healthcare company's shares were trading down by almost 12%, according to data compiled by S&P Global Market Intelligence. That fall can be traced to a new take on the company from a pundit following its trajectory.
A downgrade